Authors: Metcalfe RS, Swinton PA, et al.
Year: 2023
Journal: Exercise and Science in Sports and Medicine
Citations: 4
Link: https://pubmed.ncbi.nlm.nih.gov/37170947/
Summary:
Study investigating individual response variability to IMT in post-acute COVID-19 syndrome (Long-COVID) patients using PrO2 device.
Key Findings:
- IMT delivered using PrO2 improved inspiratory muscle strength following Long-COVID
- Identified patient characteristics predicting better IMT response:
- More severe baseline dyspnea predicted greater improvement
- Initiating IMT >3 months post-infection associated with better outcomes
- Individual treatment effects varied based on symptom severity and timing
- Personalized treatment approaches may optimize outcomes
- PrO2 training addresses persistent respiratory symptoms in COVID-19 recovery
Clinical Implications:
- Patient selection and timing matter for IMT effectiveness in Long-COVID
- More symptomatic patients may benefit most from PrO2 training
- Later intervention (>3 months) may be more effective than early intervention
- Supports personalized rehabilitation approach based on symptom severity
- PrO2 provides objective measurement to track individual treatment response